Neuroscience
Firefly Neuroscience Announces Partnership to Integrate and Distribute its BNA Technology with Zeto's EEG Device Platform
Firefly Neuroscience
PR-09-24-NI-03Sep 10, 2024
Biosimilars
Tanvex Appoints Biopharma Industry Veteran Stephen Lam as CEO
Tanvex Biopharma
PR-09-24-NI-02Sep 05, 2024
Breakthrough Results
Breakthrough Results for Jardiance® (Empagliflozin) Confirm Emperor-preserved as First and Only Successful Trial for Heart Failure with Preserved Ejection Fraction
Eli Lilly and Company
PR-M07-21-04Sep 05, 2024
M&A
Olon Continues its Growth Path and Announces a New Acquistion
Olon
PR-09-24-NI-01Sep 04, 2024
Capacity Expansion
CiVentiChem Increases Capacity by 300% with New Facility; Celebrates 30th Anniversary
CiVentiChem
PR-08-24-NI-02Aug 13, 2024
CEO Appointment
Bio X Cell Announces CEO Appointment
Bio X Cell
PR-08-24-NI-01Aug 12, 2024
Cell Therapy
Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA
Genezen
PR-07-24-NI-01Jul 02, 2024
Monoclonal Antibodies
Coriolis Pharma Launches U.S. Entity Alongside Innovative Drug Product Platform Service Offerings for Monoclonal Antibodies
Coriolis Pharma
PR-05-24-NI-02Jun 18, 2024
Sterile Fill-Finish
PCI Pharma Services Begins Installation of Sterile Fill-Finish and Lyophilization Line as Part of $100 Million New Facility Expansion
PCI Pharma Services
PR-M05-24-01May 02, 2024
FDA Approval
Possible New Hope for Metastatic Cancer Patients: Food and Drug Administration Grants Approval for Clinical Trials For Lamassu's Groundbreaking Cancer Treatment Protocol
Lamassu Biotech
PR-M04-24-01Apr 19, 2024
ESG
Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report
PCI Pharma Services
PR-M03-24-04Mar 27, 2024
Lead Share Agreement
List Biotherapeutics and Sacco System Announce Lead Share Agreement
List Biotherapeutics
PR-M03-24-03Mar 14, 2024
Biomanufacturing
Antheia and Olon Continue Partnership for Biomanufacturing Antheia’s Pipeline of KSMs and APIs for Essential Medicines
Antheia
PR-M03-24-02Mar 13, 2024
Manufacturing Partnership
Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children’s Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy Program
Genezen
PR-M03-24-01-5831Mar 06, 2024
Clinical Trial Enrollment
NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial
NMDP
PR-M03-24-01Mar 05, 2024
Portable CMC
Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use
Wheeler Bio
PR-M02-29-01Feb 29, 2024
Lentivirus Production
Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System
Genezen
PR-M02-05-02Feb 21, 2024
High Potency API Suite
Expanding Capabilities for Clients:Olon to Open New High Potency API Suite in US
Olon
PR-M02-24-01Feb 05, 2024
CDMO Rebranding
Suanfarma Unifies Its Industrial Brands in a Rebranding Initiative Under Suanfarma CDMO
Suanfarma CDMO
PR-M01-24-03Jan 31, 2024
Appointment
SGD Pharma Announces the Appointment of Fabio Invernizzi, General Manager West Business Unit
SGD Pharma
PR-M01-24-02Jan 17, 2024